According to INmune Bio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.28. At the end of 2024 the company had a P/S ratio of > 1000.
Year | P/S ratio | Change |
---|---|---|
2024 | > 1000 | 88.26% |
2023 | > 1000 | 330.35% |
2022 | 304 | -69.75% |
2021 | > 1000 | -95.27% |
2020 | > 1000 | |
2019 | N/A |